Evidence map›Paper›PMID 34586341›Full record

ArticleThe Journal of experimental medicine2021

Activated PI3Kδ signals compromise plasma cell survival via limiting autophagy and increasing ER stress.

Fahd Al Qureshah, Sara Sagadiev, Christopher D Thouvenel, Shuozhi Liu, Zhaolin Hua, Baidong Hou, Mridu Acharya, Richard G James, David J Rawlings

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Activated PIK3CD drives marginal zone B cell development from early transitional progenitors by enhancing ADAM10 expression.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fahd Al QureshahCenter for Immunity and Immunotherapy, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0002-5022-9917
Sara SagadievCenter for Immunity and Immunotherapy, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0002-8371-0977
Christopher D ThouvenelCenter for Immunity and Immunotherapy, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0001-8266-975X
Shuozhi LiuCenter for Immunity and Immunotherapy, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0002-9067-1195
Zhaolin HuaInstitute of Biophysics, Chinese Academy of Sciences, Beijing, China.ORCID 0000-0001-9242-1387
Baidong HouInstitute of Biophysics, Chinese Academy of Sciences, Beijing, China.ORCID 0000-0002-0892-0181
Mridu AcharyaCenter for Immunity and Immunotherapy, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0001-7078-2560
Richard G JamesCenter for Immunity and Immunotherapy, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0002-2302-7367
David J RawlingsCenter for Immunity and Immunotherapy, Seattle Children's Research Institute, Seattle, WA.ORCID 0000-0002-0810-1776

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
An integrated strategy to define the functional and synergistic impact of T1D causal variantsDP3DK111802 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2016 to 2016
$4.4M
Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphomaR01CA201135 · NCI · SEATTLE CHILDREN'S HOSPITAL · PI JAMES, RICHARD GOFF · 2017 to 2021
$2.1M
Role of Dock8 in Mucosal ImmunityR01AI140626 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI JAMES, RICHARD GOFF, PILIPONSKY, ADRIAN M · 2018 to 2022
$1.7M
NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA201135NIAID NIH HHS R01 AI140626NIDDK NIH HHS DP3 DK111802NIH HHS DP3-DK111802
6 · The paper itself

Abstract

While phosphatidylinositide 3-kinase delta (PI3Kδ) plays a critical role in humoral immunity, the requirement for PI3Kδ signaling in plasma cells remains poorly understood. Here, we used a conditional mouse model of activated PI3Kδ syndrome (APDS), to interrogate the function of PI3Kδ in plasma cell biology. Mice expressing a PIK3CD gain-of-function mutation (aPIK3CD) in B cells generated increased numbers of memory B cells and mounted an enhanced secondary response but exhibited a rapid decay of antibody levels over time. Consistent with these findings, aPIK3CD expression markedly impaired plasma cell generation, and expression of aPIK3CD intrinsically in plasma cells was sufficient to diminish humoral responses. Mechanistically, aPIK3CD disrupted ER proteostasis and autophagy, which led to increased plasma cell death. Notably, this defect was driven primarily by elevated mTORC1 signaling and modulated by treatment with PI3Kδ-specific inhibitors. Our findings establish an essential role for PI3Kδ in plasma cell homeostasis and suggest that modulating PI3Kδ activity may be useful for promoting and/or thwarting specific immune responses.

Indexed as

AnimalsAutophagyB-LymphocytesCell SurvivalClass I Phosphatidylinositol 3-KinasesEndoplasmic Reticulum StressFemaleGain of Function MutationGene Expression RegulationImmunity, HumoralMaleMechanistic Target of Rapamycin Complex 1MiceMice, Inbred C57BLMice, Mutant StrainsPlasma CellsClass I Phosphatidylinositol 3-KinasesMechanistic Target of Rapamycin Complex 1Pik3cd protein, mouse

Identifiers

PMID34586341
PMCPMC8485856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.